Legal Representation
Attorney
Albert P. Halluin
USPTO Deadlines
Application History
19 eventsDate | Code | Type | Description |
---|---|---|---|
Feb 6, 2009 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Feb 6, 2009 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Jun 27, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jun 27, 2008 | GNRT | O | NON-FINAL ACTION E-MAILED |
Jun 27, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jun 6, 2008 | ALIE | A | ASSIGNED TO LIE |
Jun 6, 2008 | RCCK | S | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
Dec 4, 2007 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Jun 4, 2007 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Dec 4, 2006 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED |
Dec 4, 2006 | CNSL | R | SUSPENSION LETTER WRITTEN |
Dec 4, 2006 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
Dec 1, 2006 | ALIE | A | ASSIGNED TO LIE |
Nov 9, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Nov 9, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
May 11, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
May 11, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN |
May 11, 2006 | GNRT | F | NON-FINAL ACTION E-MAILED |
Mar 17, 2006 | NWAP | I | NEW APPLICATION ENTERED IN TRAM |
Detailed Classifications
Class 001
enzymes for use in the biotechnology, agricultural and chemical industries
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
pharmaceuticals for the treatment of thrombolytic diseases, heart diseases and vascular disorders
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
HAL ENZYME
Classification
International Classes
001
005
USPTO Documents
Loading USPTO documents...